Spectramed Inc., a Newport Beach medical products...
Spectramed Inc., a Newport Beach medical products maker, reported a second-quarter loss of $1.6 million, contrasted with a profit of $2 million in the year-ago period.
Sales for the quarter ended June 30 were $18.6 million, up 1.6% from the $18.3 million last year.
Spectramed, which recently became a publicly held company, was the medical products division of Gould Inc. until October, 1986, when its management led a leveraged buyout of the operation and created a new company. Its initial stock offering was made last month.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
